Abstract | PURPOSE: To analyze the incidence and prognostic factors of ipsilateral breast tumor recurrence (IBTR) after breast-conserving therapy (BCT) in a large, population-based, single-center study with long-term follow-up. METHODS AND MATERIALS: We analyzed 3595 cases in which BCT was performed in 3824 women with stage I or II breast cancer. The incidence of IBTR was analyzed over time and was based on IBTR as first event. RESULTS: The 15-year local relapse-free survival was 90.9%. The hazard estimates for IBTR showed a time course with 2 peaks, the first at approximately 5 years and the second, twice as high, at 12 years. Stratifying subjects by age and margin status showed that, for women ≤40 years old with negative margins, adjuvant systemic therapy led to a 5-fold reduced risk of recurrence compared to none, and the presence of lymph vascular space invasion (LVSI) had a 3-fold increased risk compared to its absence. For women >40 years old, the presence of LVSI (hazard ratio [HR] 2.5) and the presence of lobular carcinoma in situ in the lumpectomy specimen (HR 2.3) were the only 2 risk factors. CONCLUSIONS: We demonstrated a pattern in risk of IBTR over time, with 2 peaks, first at approximately 5 years and a second, much higher peak at approximately 12 years, especially for women ≤40 years old. For women ≤40 years old with tumor-free resection margins, we noted that the absence of adjuvant systemic therapy and the presence of LVSI were independent prognostic factors of IBTR. For women >40 years old, the presence of LVSI and the presence of lobular carcinoma in situ were independent risk factors.
|
Authors | Jan Jobsen, Job van der Palen, Sietske Riemersma, Harald Heijmans, Francisca Ong, Henk Struikmans |
Journal | International journal of radiation oncology, biology, physics
(Int J Radiat Oncol Biol Phys)
Vol. 89
Issue 5
Pg. 1006-1014
(Aug 01 2014)
ISSN: 1879-355X [Electronic] United States |
PMID | 25035203
(Publication Type: Journal Article)
|
Copyright | Copyright © 2014 Elsevier Inc. All rights reserved. |
Topics |
- Adult
- Age Factors
- Aged
- Axilla
- Breast Neoplasms
(epidemiology, pathology, therapy)
- Carcinoma in Situ
(epidemiology, pathology, therapy)
- Carcinoma, Lobular
(epidemiology, pathology, therapy)
- Disease-Free Survival
- Female
- Humans
- Incidence
- Lymph Node Excision
- Lymph Nodes
(pathology)
- Mastectomy, Segmental
- Middle Aged
- Neoplasm Grading
- Neoplasm Invasiveness
(pathology)
- Neoplasm, Residual
- Neoplasms, Second Primary
(epidemiology, pathology)
- Proportional Hazards Models
- Prospective Studies
- Time Factors
|